В ходе исследования выявлены статистически достоверные отличия показателей иммунного статуса спортсменок-легкоатлеток после курсового приема иммуномодулирующего препарата. Установлено, что курсовой прием иммуномодулирующих препаратов улучшает адаптационные возможности организма спортсменок-легкоатлеток, что проявляется четко выраженной активацией клеточного звена иммунитета и фагоцитоза.
В ході дослідження виявлені статистично достовірні відмінності показників імунного статусу спортсменок-легкоатлеток після курсового прийому імуномодулюючого препарату. Встановлено, що курсовий прийом імуномодулюючих препаратів покращує адаптаційні можливості організму легкоатлеток, що проявляється чітко вираженою активацією клітинної ланки імунітету і фагоцитозу.
Modern elite sport requires a training loads of large volume and intensity, which are often excessive and may contribute to various diseases when the maximum athletic performance. With intense physical activity, especially in the preparatory and competitive periods in athletes may experience significant fluctuations in the parameters of immunity, which in some cases leads to the development of secondary immunodeficiency states that limit physical performance. Disorders of the immune status with the training loads can lead to a strain on the body, causing a decrease in its resistance to the action of factors external and internal environment. During intense exercise there is a significant decrease in immunity, increases the risk of penetration of pathogens and reactivation of dormant (latent) infection. Purpose: study the effect of course taking immunomodulation drug on the immune status of women-athletes on the background of physical activity in precompetitive mezocycle. Materials and Methods: the study involved 20 qualified sportswomen-athletes for run on sprint. Results: After receiving a course of immunomodulatory drug for women-athletes in the experimental group was observed activation of cellular, humoral immunity and phagocytosis. There has been an increase in the majority of the immune status of athletes and at the end of precompetitive mezocycle they were significantly higher relative to similar items in the control group. Conclusions: the study found statistically significant differences in the immune status of women-athletes after the course taking immunomodulation drug. it was found that the exchange rate improves the reception of immunomodulatory drugs adaptation abilities of women-athletes that manifests a distinct activation of cellular immunity and phagocytosis.
